Abstract PS2-04-09: Impact of prior treatment exposure and clinical-pathological factors on response and survival with Sacituzumab govitecan in advanced breast cancer: a consecutive real-world series
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps2-04-09